Tag: Heart / Stroke-Related: Stroke
AHA: Mavacamten May Treat Hypertrophic Cardiomyopathy
Improvements in cardiac structure, function seen at 30 weeks of treatment with mavacamten versus placebo
Stroke Risk Increased With Depressive Symptoms
Middle-aged and older Black and White adults have increased stroke risk with CES-D-4 scores of 1 to 3, 4 or more
COVID-19-Linked Ischemic Strokes More Severe
More severe disability on discharge and more inpatient death reported for ischemic stroke in COVID-19 patients versus controls
Two-Thirds of U.S. Adults Have Recommended Stroke Knowledge
Considerable difference in stroke knowledge found by race, Hispanic origin, with highest prevalence among non-Hispanic Whites
Major Neurological Disorders on the Rise in the United States
Burden increasing largely due to aging of the U.S. population
Incidence of Cerebrovascular Disease Quantified in COVID-19
1.4 percent of patients with COVID-19 have acute cerebrovascular disease, most often acute ischemic stroke
Many U.S. Young Adults Not Aware of Stroke Symptoms
28.9 percent of young adults not aware of all five stroke symptoms; 2.7 percent not aware of any
Weekend Admission Tied to Higher Stroke Mortality
Admission for hemorrhagic stroke on weekends versus weekdays tied to higher mortality at both rural, urban hospitals
T2DM Links to Risk for Dementia Differ by Type, Glycemic Control
Dose-response association shows higher risk for dementia with HbA1c >87 versus <52 mmol/mol
Remote Ischemic Postconditioning May Aid Stroke Recovery
More patients with acute ischemic stroke in RIPC group had excellent recovery at three months
